/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.06%
Natural Gas
+0.76%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.98%
VIX
N/A
Economic Calendar
EUR/USD
+0.06%
Natural Gas
+0.76%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.98%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
French Industrial Production Rebounds in April
about 1 hour ago
ISM Manufacturing PMI Missed Expectations, Indicating A Faster Rate Of Contraction
about 19 hours ago
ADP Report Reveals Strong Job Growth, Mixed Sector Performance in May
about 21 hours ago
German Manufacturing PMI and Retail Sales Send Mixed Signals
1 day ago
China Caixin Manufacturing PMI Brings Market Relief
1 day ago
Salesforce Surpasses Earnings Expectations, Raises Guidance
1 day ago
NASDAQ 100, Dow Jones, S&P 500: Stock Futures Show Slight Gains, Attention Shifts to Jobs Report
about 1 hour ago
USD/JPY Forecast: US Non-Farm Payrolls Report Sets the Tone
about 3 hours ago
Gold Price Forecast: XAU Set for Strong Weekly Gain on Fed’s Pause, Debt-Ceiling Progress
about 4 hours ago
Oil Price Forecast: Edging Higher on Debt Ceiling Bill, OPEC+ Meeting Expectations
about 4 hours ago
ETH Bulls Eye $2,000 on Staking Inflow Surge and Debt Ceiling Deal
about 4 hours ago
DAX Set for a Bullish Open on Debt Ceiling Vote and Fed Bets
about 5 hours ago
Quick Links
:
Forecasts
Economic Calendar
Crypto
Commodities
FXTM Academy
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
PCRX
profile
Pacira BioSciences Inc
Follow
PCRX
(
Nasdaq - US
)
Closed
38.04
+0.01 (+0.03%)
in
:
usd
•
As of: Jun 01, 2023 15:59
UTC -4
Open
37.55
High
38.38
Low
37.31
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Pacira BioSciences Inc
CEO
David Stack
Headquarters
5401 west kennedy boulevard, suite 890
tampa, fl 33609, united states
Auditor
KPMG LLP
Employees
715
Share Holders
11
Website
www.pacira.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug delivery technology. Pacira changed its name to Pacira BioSciences following the acquisition of MyoScience. Exparel, the company's flagship product, is a liposome injection of bupivacaine, which is indicated for single-dose administration into the surgical site to produce postsurgical analgesia. The company signed a licensing agreement with Aratana for the development and commercialization of Exparel for animal health indications.
Pacira BioSciences Inc
Statistics
Valuation Measures
Market Capitalization
2
1.75B
Enterprise Value
2.27B
Enterprise Value/EBITDA
(ttm)
16.49
Price to Earnings Ratio
(ttm)
23.37
Price to Book
(mrq)
2.35
Price to Sales
(ttm)
2.70
Price to Cash
(ytd)
9.77
Profitability
Gross Margin
(ttm)
68.32%
Operating Margin
(ttm)
11.61%
Profit Margin
(ttm)
-1.69%
Return on Equity
(ttm)
10.12%
Return on Invested Capital
(ttm)
-0.90%
Return on Assets
(ttm)
4.66%
Income Statement
Revenue
(ttm)
669.17M
Revenue Per Share
(ttm)
14.55
Gross Profit
(ttm)
456.93M
EBITDA
(ttm)
3
137.54M
Net Income Avi to Common
(ttm)
-10.46M
Diluted EPS
(ttm)
-0.27
Share Statistics
Beta (5Y Monthly)
0.76
52-Week Change
-41.72%
S&P500 52-Week Change
1.06%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
45.99M
Dividend Yield
0.00%
Float
4
42.95M
%
Held by Insiders
6.60%
%
Held by Institutions
N/A
Balance Sheet
Total Cash
(mrq)
174.00M
Total Cash Per Share
(mrq)
3.78
Total Debt
(mrq)
553.77M
Total Debt/Equity
(mrq)
72.10%
Current Ratio
(mrq)
3.81%
Quick Ratio
(mrq)
2.87%
Book Value Per Share
(mrq)
16.71
Cash Flow
Operating Cash Flow Per Share
(ytd)
0.42
Free Cash Flow
(ytd)
12.56M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker